The Diagnosis Value of Serum Marker in Stroke Associated With Nonvalvular Atrial Fibrillation. "CE"

Recruiting

Phase N/A Results N/A

Trial Description

The purpose of this study is to evaluate the diagnostic value of serum NT - proBNP in stroke associated with nonvalvular atrial fibrilltion.

Detailed Description

All included in the cases in 7 days of blood samples, the detection of serum NT - proBNP.Through the single factor analysis to determine the serum NT - proBNP central source sex stroke prediction values.

Conditions

Trial Design

  • Observation: Case Control
  • Perspective: Prospective
  • Sampling: Probability Sample

Trial Population

18 ≤ Age ≤ 85; meet the clinical diagnostic criteria for acute ischemic stroke; onset within 24 hours at the same time more than one hour; it was diagnosed with experiential doctor.

Outcomes

Type Measure Time Frame Safety Issue
Primary The diagnostic value of serum NT - proBNP and D-dimer for cardioembolic stroke 34 months No
Primary The diagnostic value of serum NT - proBNP in stroke associated with nonvalvular atrial fibrilltion 34 months No

Biospecimen Retention:Samples Without DNA - NT-proBNP

Sponsors